Xencor's (XNCR) CEO Bassil Dahiyat on Q3 2021 Results - Earnings Call Transcript

Xencor, Inc. (NASDAQ:XNCR) Q3 2021 Earnings Conference Call November 8, 2021 4:30 PM ET

Company Participants

Charles Liles – Head-Corporate Communications and Investor Relations
Bassil Dahiyat – President and Chief Executive Officer
Allen Yang – Chief Medical Officer
John Desjarlais – Chief Scientific Officer
John Kuch – Chief Financial Officer

Conference Call Participants

Ted Tenthoff – Piper Sandler
Mara Goldstein – Mizuho
David Nierengarten – Wedbush Securities
Kaveri Pohlman – BTIG
Charles Zhu – Guggenheim Securities
Peter Lawson – Barclays

Operator

Good day and thank you for standing by. Welcome to the Third Quarter 2021 Xencor Conference Call. [Operator Instructions]

I would like to hand the conference over to your speaker for today, Charles Liles, Head of Corporate Communications and Investor Relations. Please go ahead.

Charles Liles

Thank you, and good afternoon. Earlier today, we issued a press release which outlines the topics we plan to discuss today. The press is available at www.xencor.com.

With me on the call today are, Bassil Dahiyat, President and Chief Executive Officer; Allen Yang, Chief Medical Officer; John Desjarlais, Chief Scientific Officer; and John Kuch, Chief Financial Officer. After the remarks we'll open up the call for your questions.

Before we begin, I would like to remind you that during the course of this conference call, Xencor management may make forward-looking statements, including statements regarding the company's future financial and operating results, future market conditions, the plans and objectives of management, future operations, the company's partnering efforts, capital requirements, future product offerings and research and development programs. These forward-looking statements are not historical facts but rather are based on our current expectations and beliefs and are based on information currently available to us. The outcome of the events described in these forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated